Joe Healey of NanoSyrinx: Interview on Cell and Gene Therapy
We interview Joe Healey, CEO and Co-Founder of NanoSyrinx, NanoSyrinx is a discovery-stage synthetic biology biotech developing a novel delivery modality for complex biologics.
Joe founded the company, along with his PhD supervisor Dr Nick Waterfield and a fellow post-doc, Dr Alexia Hapeshi, during his PhD at the University of Warwick’s Medical School, and has been the entrepreneurial lead driving the development of the company from its inception.
In part 1 of this interview, we find out more about the story behind the company.
In part 2 of this interview, Joe discusses the biggest trends in the cell and gene therapy space, investment, and the future.
Joe was recently a speaker at Advanced Therapies Integrates on the “Fast Forward” panel